Northern Trust’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Northern Trust’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,325	Closed	-$21K	–	4827
2022 Q2	$21K	Sell	18,325 -6	-0%	-$10	﹤0.01%	4621
2022 Q1	$93K	Sell	18,331 -191	-1%	-$1.2K	﹤0.01%	4369
2021 Q4	$104K	Hold	18,522	–	–	﹤0.01%	4409
2021 Q3	$205K	Sell	18,522 -1,126	-6%	-$14.1K	﹤0.01%	4168
2021 Q2	$333K	Sell	19,648 -35,368	-64%	-$670K	﹤0.01%	3889
2021 Q1	$1.45M	Sell	55,016 -1,909	-3%	-$86.8K	﹤0.01%	3421
2020 Q4	$2.06M	Sell	56,925 -1,366	-2%	-$49.4K	﹤0.01%	3177
2020 Q3	$2.06M	Buy	58,291 +22,345	+62%	+$971K	﹤0.01%	3045
2020 Q2	$1.53M	Buy	35,946 +23,891	+198%	+$1.61M	﹤0.01%	3181
2020 Q1	$962K	Buy	12,055 +1,351	+13%	+$108K	﹤0.01%	3240
2019 Q4	$991K	Sell	10,704 -1,861	-15%	-$157K	﹤0.01%	3402
2019 Q3	$950K	Buy	12,565 +7,718	+159%	+$593K	﹤0.01%	3409
2019 Q2	$483K	Buy	4,847 +2,565	+112%	+$199K	﹤0.01%	3558
2019 Q1	$120K	Buy	+2,282	New	+$124K	﹤0.01%	3886
2018 Q1	–	Sell	-115	Closed	-$20K	–	4290
2017 Q4	$20K	Hold	115	–	–	﹤0.01%	4157
2017 Q3	$5K	Hold	115	–	–	﹤0.01%	4222
2017 Q2	$6K	Hold	115	–	–	﹤0.01%	4243
2017 Q1	$17K	Buy	+115	New	+$14.9K	﹤0.01%	4170

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Northern Trust's EVFM Position: Q3 2022 in Review

Northern Trust sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 18,325 shares — an estimated $21K sold.

Northern Trust first reported a position in EVFM in Q1 2017 and held it in 18 quarters. The position peaked at $2.06M in Q3 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

Northern Trust reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Northern Trust sold 18,325 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $21K.
Northern Trust first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2017 and held it in 18 quarters.
Northern Trust's Evofem Biosciences, Inc. Common Stock position peaked at $2.06M in Q3 2020.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.